What is the Future of 3D Bioprinting in Toxicology?
3D bioprinting involves creating three-dimensional structures composed of cells and biomaterials that replicate human tissues. This technology holds promise for toxicology by enabling the creation of complex tissue models that better mimic human physiology than traditional 2D cell cultures. These models can be used for more accurate testing of drug toxicity and efficacy, potentially transforming the fields of drug discovery and personalized medicine.